Skip Nav Destination
FDA Approves Drug Combo for Kidney Cancer
Cancer Discov (2016) 6 (7): 687–688.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Angelina T. Regua
- Mariana Najjar
- Hui-Wen Lo
Frontiers in Oncology (2022) 12
- Zhi-Mei Li
- Guan Liu
- Ya Gao
- Ming-Gao Zhao
Pharmacology & Therapeutics (2022) 240: 108229.
- E. Grande
- H. Glen
- J. Aller
- G. Argenziano
- M. J. Lamas
- P. Ruszniewski
- J. L. Zamorano
- K. Edmonds
- S. Sarker
- M. Staehler
- J. Larkin
Cancer Urology (2021) 16 (4): 61.
- Alok Goel
- Anshul Singla
Cancer Research, Statistics, and Treatment (2021) 4 (4): 709.
- Martin H. Voss
- Rupal S. Bhatt
- Elizabeth R. Plimack
- Brian I. Rini
- Robert S. Alter
- J. Thaddeus Beck
- Dawn Wilson
- Xiaosha Zhang
- Musa Mutyaba
- Chad Glasser
- Kenneth M. Attie
- Matthew L. Sherman
- Shuchi S. Pandya
- Michael B. Atkins
Clinical Cancer Research (2017) 23 (14): 3557.
- Yun Zou
- Jianfeng Wang
- Xuejiao Leng
- Jiwei Huang
- Wei Xue
- Jin Zhang
- Yiran Huang
Oncotarget (2017) 8 (13): 20825.
- E Grande
- H Glen
- J Aller
- G Argenziano
- MJ Lamas
- P Ruszniewski
- JL Zamorano
- K Edmonds
- S Sarker
- M Staehler
- J Larkin
Expert Opinion on Drug Safety (2017) 16 (12): 1413.
